Cited by 792Hormonal and reproductive studiesBone health and osteoporosis researchGrowth Hormone and Insulin-like Growth Factors

The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.

Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism.

Katznelson, L, Finkelstein, J S, Schoenfeld, D A, Rosenthal, D I, Anderson, E J, Klibanski, A·1996·The Journal of Clinical Endocrinology & Metabolism

DOI 10.1210/jcem.81.12.8954042

Open this paper in CoChat — free account

Abstract

Acquired hypogonadism is being increasingly recognized in adult men. However, the effects of long term testosterone replacement on bone density and body composition are largely unknown. We investigated 36 adult men with acquired hypogonadism (age, 22-69 yr; median, 58 yr), including 29 men with central hypogonadism and 7 men with primary hypogonadism, and 44 age-matched eugonadal controls. Baseline evaluation included body composition analysis by bioimpedance, determination of site-specific adipose area by dual energy quantitative computed tomography scan (QCT) of the lumbar spine, and measurements of spinal bone mineral density (BMD) using dual energy x-ray absortiometry, spinal trabecular BMD with QCT, and radial BMD with single photon absorptiometry. Percent body fat was significantly greater in the hypogonadal men compared to eugonadal men (mean +/- SEM, 26.4 +/- 1.1% vs. 19.2 +/- 0.8%; P < 0.01). The mean trabecular BMD determined by QCT for the hypogonadal men was 115 +/- 6 mg K2HPO4/cc. Spinal BMD was significantly lower than that in eugonadal controls (1.006 +/- 0.024 vs. 1.109 +/- 0.028 g/cm2; P = 0.02, respectively). Radial BMD was similar in both groups. Testosterone enanthate therapy was initiated in 29 hypogonadal men at a dose of 100 mg/week, and the subjects were evaluated at 6-month intervals for 18 months. During testosterone therapy, the percent body fat decreased 14 +/- 4% (P < 0.001). There was a 13 +/- 4% decrease in subcutaneous fat (P < 0.01) and a 7 +/- 2% increase in lean muscle mass (P = 0.01) during testosterone therapy. Spinal BMD and trabecular BMD increased by 5 +/- 1% (P < 0.001) and 14 +/- 3% (P < 0.001), respectively. Radial BMD did not change. Serum bone-specific alkaline phosphatase and urinary deoxypyridinoline excretion, markers of bone formation and resorption, respectively, decreased significantly over the 18 months (P = 0.003 and P = 0.04, respectively). We conclude that testosterone therapy given to adult men with acquired hypogonadism decreases sc fat and increases lean muscle mass. In addition, testosterone therapy reduces bone remodeling and increases trabecular bone density. The beneficial effects of androgen administration on body composition and bone density may provide additional indications for testosterone therapy in hypogonadal men.

Integrity signals

Registry

Crossref · 10.1210/jcem.81.12.8954042

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Hip fractures in the elderly: A world-wide projection
Cooper, C. C., Campion, G., & Melton, L. J. (1992) · Osteoporosis International · doi:10.1007/bf01623184 · Cited by 3,225
Measurement of Bone Mineral in vivo: An Improved Method
CAMERON, J. R., & Sorenson, J. A. (1963) · Science · doi:10.1126/science.142.3589.230 · Cited by 827
Effects of testosterone supplementation in the aging male.
Tenover, J. S. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.75.4.1400877 · Cited by 702
Risk factors for spinal osteoporosis in men
Seeman, E., Melton, L. J., O’Fallon, W. M., & Riggs, B. L. (1983) · The American Journal of Medicine · doi:10.1016/0002-9343(83)90878-1 · Cited by 658
Testosterone administration to elderly men increases skeletal muscle strength and protein synthesis
Urban, R. J., Bodenburg, Y. H., Gilkison, C., Foxworth, J., Coggan, A. R., Wolfe, R. R., & Ferrando, A. (1995) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1995.269.5.e820 · Cited by 608
Osteoporosis: Etiology, diagnosis, and management
(1996) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(97)80791-1 · Cited by 605
Visceral fat accumulation in men is positively associated with insulin, glucose, and C-peptide levels, but negatively with testosterone levels
Seidell, J. C., Björntorp, P., Sjöström, L., Kvist, H., & Sannerstedt, R. (1990) · Metabolism · doi:10.1016/0026-0495(90)90297-p · Cited by 567
Effects of Testosterone Replacement Therapy in Old Hypogonadal Males: A Preliminary Study
Morley, J. E., Perry, H. M., Kaiser, F. E., Kraenzle, D., Jensen, J., Houston, K., Mattammal, M. B., & Perry, H. M. (1993) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1993.tb02049.x · Cited by 462
Regulation of interleukin-6, osteoclastogenesis, and bone mass by androgens. The role of the androgen receptor.
Bellido, T., Jilka, R. L., Boyce, B. F., Girasole, G., Broxmeyer, H. E., Dalrymple, S. A., Murray, R., & Manolagas, S. C. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117995 · Cited by 429
Castrated Men Exhibit Bone Loss: Effect of Calcitonin Treatment on Biochemical Indices of Bone Remodeling*
Stepan, J. J., Lachman, M., ZVĚŘINA, J., Pacovský, V., & Baylink, D. J. (1989) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-69-3-523 · Cited by 423

Show all 38 references

Sorted by citations

Items 601–700 of 792

EFEITO DA SUPLEMENTAÇÃO ALIMENTAR SOBRE AÇÃO ANABÓLICA DO DECANOATO DE NANDROLONA EM RATOS
Fermo, R. S., Rego, J. N. I., Franquini, J. V. M., et al. (2008) · Revista Eletrônica de Farmácia · doi:10.5216/ref.v5i1.4621 · Cited by 4
Chronic Pain and Opioids
Szucs-Reed, R. P., & Gallagher, R. M. (2011) · Springer eBooks · doi:10.1007/978-1-4419-1651-8_29 · Cited by 4
Anabolic Therapy of Osteoporosis in Women and in Men
Rubin, M. R., & Bilezikian, J. P. (2004) · Principles of Gender-Specific Medicine · doi:10.1016/b978-012440905-7/50366-2 · Cited by 4
Die Osteoporose beim Mann
Kudlacek, S., Freudenthaler, O., Resch, H., & Willvonseder, R. (2000) · Journal für Kardiologie (Krause & Pachernegg GmbH) · Cited by 4
Bisphosphonates and glucocorticoid osteoporosis in men: results of a randomized controlled trial comparing zoledronic acid with risedronate
Sambrook, P. N., Roux, C., Devogelaer, J.-P., Saag, K., Lau, C.-S., Reginster, J.-Y., Bucci-Rechtweg, C., Su, G., & Reid, D. M. (2012) · Bone · doi:10.1016/j.bone.2011.10.024 · Cited by 3
“Previous reports have shown that in men, testosterone promotes bone formation and inhibits bone resorption [38,39].”
Background
Testosterone, sex hormone-binding globulin, and fracture risk in men: evidence from observational and Mendelian randomization analyses
Luo, Z., Feng, A., Tyurin, A. V., Cui, Q., Rita, K. S., Xie, Z., Ildar, M., An, R., Chen, S., Zhang, Y., et al. (2025) · Osteoporosis International · doi:10.1007/s00198-025-07620-z · Cited by 3
“Testosterone is a key regulator of bone homeostasis, and declining sex steroid levels with age have been consistently linked to increased fracture risk, particularly among men with hypogonadism [6, 7].”
Incomplete Evidence of Bone Density Normalization Following Long-Term Reproductive Hormone Treatment in Men With Hypogonadotropic Hypogonadism
de Silva, N. L., Hyams, E., Grant, B., Dixit, P., Bassi, R., Bassett, P., Comninos, A. N., & Jayasena, C. N. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf488 · Cited by 4
Predictive Value of Native Computed Tomography in Low Energy Vertebra Fracture Risk Assessment
Bokov, A., Aleynik, A. Y., Rasteryaeva, M. V., et al. (2016) · Spine Research · doi:10.21767/2471-8173.100009 · Cited by 3
Indications for testosterone therapy in men
Grossmann, M. (2024) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000890 · Cited by 6
Testosterone Deficiency or Male Hypogonadism
Koch, C. A., & Zitzmann, M. (2012) · Humana Press eBooks · doi:10.1007/978-1-60761-548-4_11 · Cited by 3
Androgen Effects on the Skeletal Muscle
Bhasin, S., Singh, R., Jasuja, R., & Storer, T. W. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374602-3.00027-4 · Cited by 3
Anabolic and Metabolic Effects of Testosterone and Other Androgens: Direct Effects and Role of Testosterone Metabolic Products
Čeponis, J., Wang, C., Swerdloff, R. S., & Liu, P. Y. (2017) · Endocrinology · doi:10.1007/978-3-319-29456-8_11-1 · Cited by 3
Androgens in male senescence
Kaufman, J., T'Sjoen, G. G., & Vermeulen, A. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9781139003353.017 · Cited by 3
Measurement of Skeletal Muscle mass of Japanese Men and Women Aged 18-84 by Bioelectrical Impedance Analysis Focusing on the Difference in Measured Values Produced by Different Equipment
Iwamura, M., Kanauchi, M., & Kajimoto, H. (2015) · Rigakuryoho Kagaku · doi:10.1589/rika.30.265 · Cited by 3
A randomized comparative trial of testosterone and protein supplements for weight loss in HIV+ men
Wagner, G. J., Rabkin, J. G., & Rabkin, R. (2001) · Nutrition Research · doi:10.1016/s0271-5317(00)00253-0 · Cited by 3
Testostérone plasmatique, obésité, syndrome métabolique et diabète
Prévost, G., Eas, F., & Kuhn, J. (2013) · La Presse Médicale · doi:10.1016/j.lpm.2013.04.023 · Cited by 3
“[13] Katznelson L, Finkelstein JS, Schoenfeld DA, Rosenthal DI, Anderson EJ, Klibanski A.”
Background
Novel Strategies for Improving Physical Function
Bhasin, S., Jasuja, R., Tu, P., Storer, T. W., & Guo, W. (2011) · Hormone Research in Paediatrics · doi:10.1159/000329148 · Cited by 3
Androgen Receptor Gene CAG Repeat Polymorphism and Effect of Testosterone Therapy in Hypogonadal Men in Korea
Kim, M. J., Kim, J. T., Cho, S. W., Kim, S. W., Shin, C. S., Park, K. S., & Kim, S. Y. (2011) · Endocrinology and Metabolism · doi:10.3803/enm.2011.26.3.225 · Cited by 3
Testosterone Replacement Therapy in Men and Women
El‐Maouche, D., & Dobs, A. S. (2010) · Principles of Gender-Specific Medicine · doi:10.1016/b978-0-12-374271-1.00060-5 · Cited by 3
Lietuvos sveikatos mokslų universitetas
Šeškevičius, A., Lesauskaitė, V., Blaževičienė, A., Kubilius, R., Samėnienė, J., Gudas, R., & Macijauskienė, J. (2018) · Lithuanian University of Health Sciences · Cited by 3
Osteoporosis and other adverse body composition changes during androgen deprivation therapy for prostate cancer
Smith, M. R. (2006) · Kluwer Academic Publishers eBooks · doi:10.1007/0-306-48143-x_26 · Cited by 3
Influence of female and male sex steroids on body composition in the rabbit model
Alexandersen, P., Hassager, C., & Christiansen, C. (2001) · Climacteric · doi:10.1080/713605101 · Cited by 3
Clinical Monitoring of Growth Hormone Replacement in Adults
Gibney, J., & Johannsson, G. (2005) · KARGER eBooks · doi:10.1159/000088418 · Cited by 3
Testosterone and the Older Man
Tenover, J. L. (1999) · Humana Press eBooks · doi:10.1007/978-1-59259-700-0_18 · Cited by 3
Commentary: Androgen replacement therapy in the aging male--a critical evaluation.
Vermeulen, A. (2001) · The Journal of Clinical Endocrinology & Metabolism · Cited by 3
Déficit androgénique: effet de la substitution sur la composition corporelle
Kuhn, J. (2002) · Andrologie · doi:10.1007/bf03034944 · Cited by 3
“La substitution androgdnique de l'homme hypogonadique 61~ve la masse maigre [9], augmente la force musculaire et la synth~se prot6ique du muscle squelettique.”
Background
A case for clarity, consistency, and helpfulness: state-of-the-art clinical practice guidelines in endocrinology using the grading of recommendations, assessment, development, and evaluation system.
Swiglo, B. A., Murad, M. H., Schünemann, H. J., Kunz, R., Vigersky, R. A., Guyatt, G. H., & Montori, V. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1907 · Cited by 302
Testosterone-Optimizing Strategies in Athletes
Lazarev, A. M., Pujalte, G. G. A., Philibert, C., Meek, S., Broderick, G. A., Zapp, D. G., Mayo, M. R., & Hackney, A. C. (2026) · Sports Health A Multidisciplinary Approach · doi:10.1177/19417381251411933 · Cited by 3
“18,94,180,199 Winning increases testosterone levels, reinforcing positive behaviors, motivation, and reactivity—critical traits for athletes.”
Osteoporosis in Men
Barham, K., Chernoff, A., & Anastasopoulou, C. (2007) · Cited by 2
Testosterone - Functions, Uses, Deficiencies, and Substitution
Doi, H. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.102212 · Cited by 2
Relationship between Androgen Deprivation Therapy and Abdominal Adipose Tissue
Greco, F., Tafuri, A., Panunzio, A., et al. (2022) · Uro · doi:10.3390/uro2040030 · Cited by 2
“Testosterone replacement therapy determines an increase in lean body mass and a decrease in fat mass in hypogonadal men [2,3].”
Background
Unlocking the therapeutic potential and personalized therapy of testosterone: a comprehensive review
Reddy, A. V., Ramasamy, K., Rajendran, P., & Deva, R. (2024) · Drug Metabolism and Personalized Therapy · doi:10.1515/dmpt-2024-0035 · Cited by 2
Testosterone Supplementation and Aging-associated Sarcopenia
Bhasin, S. (2004) · Research and perspectives in endocrine interactions · doi:10.1007/978-3-662-07019-2_12 · Cited by 2
Effect of Androgen Receptor on Bone Sialoprotein Gene Transcription
Takai, H., & Ogata, Y. (2007) · 日本歯周病学会会誌 · doi:10.2329/perio.49.27 · Cited by 2
HRT for the Aging Male: A Therapy That Has Come of Age?
Tenover, J. L. (2000) · Springer eBooks · doi:10.1007/978-1-4612-2106-7_8 · Cited by 2
Rol' korrektsii gipogonadizma v lechenii metabolicheskogo sindroma u muzhchin
Kalinchenko, S. Y., & Tishova, Y. A. (2006) · Obesity and metabolism · doi:10.14341/2071-8713-4867 · Cited by 2
II. Changes in Reproductive Hormones During the Aging Process
Bagatell, C. J., & Bremner, W. J. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.10.5060-2 · Cited by 2
Conjugated linoleic acid mitigates testosterone-related changes in body composition in male guinea pigs
Yang, S. Q., DeGuire, J. R., Lavery, P., Mak, I. L., Weiler, H. A., & Santosa, S. (2016) · Nutrition Research · doi:10.1016/j.nutres.2015.12.013 · Cited by 2
“percent body fat in hypogonadal men is 7% higher than in eugonadal men of the same age and race [6].”
Background
In vitro and in vivo evaluation of a novel testosterone transdermal delivery system (TTDS) using palm oil base.
Haron, D. E. M., Chik, Z., Noordin, M. I., & Mohamed, Z. (2015) · PubMed Central · Cited by 2
Testosterone deficiency syndrome in elderly men: current views
Rabijewski, M. (2013) · Menopause Review/Przegląd Menopauzalny · doi:10.5114/pm.2013.33419 · Cited by 2
“Stosowanie hormonalnego leczenia zastępczego testosteronem istotnie wpływa na metabolizm: wzrasta masa i siła mięśniowa, masa tkanki kostnej, poprawia się profil lipidowy, zmniejsza insulinemia i insulinooporność oraz masa tkanki tłuszczowej, a zwiększa beztłuszczowa masa ciała [32–35].”
Background
CLINICAL PRACTICE GUIDELINE Testosterone Therapy in Adult Men with Androgen Deficiency Syndromes: An Endocrine Society Clinical Practice Guideline
Bhasin, S., Cunningham, G. R., Hayes, F. J., Matsumoto, A. M., Snyder, P. J., Swerdloff, R. S., & Montori, V. M. (2010) · Cited by 2
Male Reproductive Aging
Snyder, P. J. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-4907-4.00015-2 · Cited by 2
Detection of Late-Onset Hypogonadism in Men with Chronic Internal Diseases
Požarskis, A., & Lejnieks, A. (2019) · Proceedings of the Latvian Academy of Sciences Section B Natural Exact and Applied Sciences · doi:10.2478/prolas-2019-0004 · Cited by 2
Male Reproductive Aging
Snyder, P. J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-47912-7.00015-9 · Cited by 2
Male Senescence
Tenover, J. L. (2007) · Springer eBooks · doi:10.1007/978-0-585-38145-9_7 · Cited by 2
Bone microarchitectural alterations associated with spinal cord injury: Relation to sex hormones, metabolic factors, and loading
Valderrábano, R. J., Pencina, K. M., Shang, Y. V., Cruz, E. C. E., Dixon, R., Ghattas, C., Wilson, L. A., Reid, K. F., Storer, T. W., Garrahan, M., et al. (2024) · Bone · doi:10.1016/j.bone.2024.117039 · Cited by 2
Alteraciones metabólicas óseas en las enfermedades endocrinológicas
Diaz‐Guerra, G. M., Gimeno, E. J., Mira, S. A., & Carranza, F. H. (2002) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/s0304-5412(02)70841-x · Cited by 2
The role of correction of hypogonadism in the treatment and prophylaxis of urolithiasis in the men presenting with metabolic syndrome
Gusakova, D., Kalinchenko, S. Y., Kamalov, A. A., & Tishova, Y. A. (2015) · Problems of Endocrinology · doi:10.14341/probl201561212-20 · Cited by 2
Gonadal hormones and their influence on skeletal health in men
Meier, C., & KRAENZLIN, M. E. (2007) · The Journal of Men s Health and Gender · doi:10.1016/j.jmhg.2006.06.007 · Cited by 2
“In hypogonadal men, testosterone administration decreases bone resorption [66,71,73,74,82] and increases bone formation [74,82,83].”
Background
From Gonads to Bone, and Back
Oury, F. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-415784-2.00011-7 · Cited by 2
Anabolic Androgenic Steroids
Haff, G. G. (2007) · Strength and conditioning journal · doi:10.1519/00126548-200702000-00009 · Cited by 2
VI. A Pragmatic Approach to Androgen Replacement in Older Men: Risks vs. Benefits
Korenman, S. G. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.10.5060-6 · Cited by 2
Hormonersatztherapie beim Mann - Sinn oder Unsinn?
Jockenhövel, F., & Schubert, M. (2003) · Journal für Kardiologie (Krause & Pachernegg GmbH) · Cited by 2
Human Immunodeficiency Virus and Hypogonadal Bone Disease
Miller, M. G., & Mulligan, T. (2005) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.25.4.632.61027 · Cited by 2
Sex Steroids and Osteoporosis: The Role of Estrogens and Androgens
Adler, R. A. (2000) · Clinics in Laboratory Medicine · doi:10.1016/s0272-2712(18)30052-0 · Cited by 2
Sex Steroids and Skeletal Health in Men
Meier, C., Liu, P. Y., Seibel, M. J., & Handelsman, D. J. (2006) · Elsevier eBooks · doi:10.1016/b978-0-323-03437-1.50023-3 · Cited by 2
The relationship between openness to experience and intelligence with sexual desire; The moderating role of weight and age
Barazandeh, M., Beshārat, M. A., & Moghadamzadeh, A. (2022) · Journal of Sexual Health Psychology · doi:10.52547/jshp.1.2.47 · Cited by 1
“These findings are consistence with previous studies (Campbell et al., 2012; Esposito et al., 2007; Katznelson et al 1996; Smith, 2004; Warnock et al., 1997).”
BackgroundResult
Potential use of barks of woody vascular plants in bone mending: A review
Joshi, D. D., Deb, L., Somkuwar, B. G., et al. (2023) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2023.101714 · Cited by 1
“The Eurycoma longifolia root aqueous decoction is a popular folk medicine to enhance the free testosterone level in the blood (Ang and Cheang, 2001) and prevent osteoporosis in the Malay region (Katznelson et al., 1996; Aminorroaya et al., 2005; Ali and Saad, 1993).”
PRDM16 Enhances Osteoblastogenic RUNX2 via Canonical WNT10b/β-CATENIN Pathway in Testosterone-Treated Hypogonadal Men
Bathina, S., Prado, M., Lopez, V. F., Colleluori, G., Aguirre, L. E., Chen, R., Villareal, D. T., & Armamento‐Villareal, R. (2025) · Biomolecules · doi:10.3390/biom15010079 · Cited by 1
Testosterone and Bone Health in Men
Kafel, H., & Basaria, S. S. (2026) · Current Osteoporosis Reports · doi:10.1007/s11914-026-00971-4 · Cited by 2
“…hypogonadism (7 with primary and 29 with secondary hypogonadism) and 44 age-matched eugonadal controls, the mean trabecular BMD at baseline assessed with quantitative computed tomography scan (QCT) was signifi - cantly lower in hypogonadal men compared with eugonadal controls (P = 0.02) [52].”
Influential
Anti-Obesity Effects of Androgens, Dehydroepiandrosterone (DHEA) and Testosterone
Kajita, K., Mori, I., Yamauchi, M., Ikeda, T., Morita, H., & Ishizuka, T. (2015) · InTech eBooks · doi:10.5772/59604 · Cited by 2
“Katznelson et al, reported that percent body fat was greater in acquired hypogonadal men compared with eugonadal controls, which was improved by testosterone replacement therapy [9].”
Osteoporosis in Men - A Crucial Role of Sex Hormones
Rabijewski, M., & Papiersk, L. (2012) · InTech eBooks · doi:10.5772/28546 · Cited by 1
“In this elderly population, effects of testosterone treatment on BMD have been inconsistent, with the most convincing effects being observed in men with very low serum testosterone (Katznelson et al. 1996; Snyder et al. 2000; Wang et al. 2001).”
Background
Romosozumab/CDP7851 for the treatment of osteoporosis
Sim, I., & Ebeling, P. R. (2015) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.2015.1079482 · Cited by 1
“Hormonal therapies, including hormone replacement therapy, selective estrogen receptor modulators, and testosterone replacement in men also have a demonstrable anti-resorptive effect [8,9].”
Background
Testosterone and Cardiovascular Disease in Men
Rothman, M. S., & Wierman, M. E. (2007) · Aging Health · doi:10.2217/1745509x.3.3.375 · Cited by 3
“As such, testosteronereplacement therapy (TRT) has been used in symptomatic hypogonadism, as well as disease states such as HIV/AIDS, cancer, osteoporosis and depression in men [10–14].”
Background
Hormone Modulation, Low Glycemic Nutrition, and Exercise Instruction: Effects on Disease Risk and Quality of Life
Leonardi, D., Mintz, A., Dotson, A., & Mukai, J. (2001) · Rejuvenation Research · doi:10.1089/10945450152850678 · Cited by 1
Hypogonadismes hypogonadotrophiques chez l'homme
Young, J. (2004) · EMC - Endocrinologie - Nutrition · doi:10.1016/s1155-1941(04)74272-9 · Cited by 1
The Relationship between Various Obesity Indices and Level of Male Hormone according to Different Age Groups
Lee, Y.-J., Kim, H.-J., & Kong, M.-H. (2014) · The Korean Journal of Obesity · doi:10.7570/kjo.2014.23.4.245 · Cited by 1
The Association of Level of Testosterone and Parameters of Obesity
Kim, C. H. (2015) · The Korean Journal of Obesity · doi:10.7570/kjo.2015.24.1.28 · Cited by 1
“남성에서 이러한 혈중 테스토스테론의 감소는 근육량의 감소, 복부 비만, 인슐린저항성의 증가를 비롯한 대사증후군의 발생과 연관이 있다.(4) 혈중 테스토스테”
Ostéopathies endocriniennes (en dehors de l'hyperparathyroïdie)
Cortet, B., Cortet‐Rudelli, C., & Trémollières, F. (2006) · EMC - Appareil locomoteur · doi:10.1016/s0246-0521(00)00063-2 · Cited by 1
Physiopathologie du déficit androgénique lié à l'âge
Shakespeare, W. (2004) · Cited by 1
[Osteoporosis in women and men--similarities and differences].
Skowrońska‐Jóźwiak, E., & Lewiñski, A. (2006) · PubMed · Cited by 1
Medical Management of Sexual Dysfunction in the Aging Male
Rubin, R. S., & Goldstein, I. (2016) · Topics in Geriatric Rehabilitation · doi:10.1097/tgr.0000000000000106 · Cited by 1
Androgens
Snyder, P. J. (2008) · Elsevier eBooks · doi:10.1016/b978-012370544-0.50079-3 · Cited by 1
The role of androgens acting via the androgen receptor in osteoblasts to regulate bone cell metabolism
Chiang, C. Y. (2017) · Minerva Access (University of Melbourne) · Cited by 1
The Effects of Androgens on Bone Metabolism: Clinical Aspects
Sfeir, J. G., & Drake, M. T. (2020) · Contemporary Endocrinology · doi:10.1007/978-3-319-69287-6_13 · Cited by 1
Androgens
Mukaddam, M. A., & Snyder, P. J. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-415853-5.00078-9 · Cited by 1
Normal Spermatogenesis
KERR, J. B. (2007) · CRC Press eBooks · doi:10.3109/9781420018813-10 · Cited by 1
Anti-Aging Medicine: Hormone Replacement Therapy in Men
Kaweski, S. (2004) · Plastic & Reconstructive Surgery · doi:10.1097/01.prs.0000125283.18798.da · Cited by 1
Preoperative Elevated Serum Growth Hormone is Preventive of Osteopenia in Postsurgical Patients With Pituitary Somatotroph Adenomas
Sasaki, M., Okazaki, R., Inoue, D., Nakashima, M., Ide, F., Nakaguchi, H., Yamada, S. M., Hoya, K., Murakami, M., Mizutani, A., et al. (2009) · The Endocrinologist · doi:10.1097/ten.0b013e3181b66096 · Cited by 1
Treatment of Hypogonadism in Men
Mehta, A., Paduch, D. A., & Goldstein, M. (2012) · Springer eBooks · doi:10.1007/978-1-4471-4405-2_5 · Cited by 1
Obesity Status and Predictors of Obesity for Military Executive Members of the Korean Army Personnel
Park, J. S., & Jang, S. Y. (2016) · Korean Journal of Adult Nursing · doi:10.7475/kjan.2016.28.2.136 · Cited by 1
“근육량 감소, 체지방량 증가, 복부비만 등의 심각한 건강문제 를 경험하게 된다[5-7].”
Retracted
Long-term Hormone Replacement Therapy in Hypopituitarism
Yamada, S., & Ozawa, Y. (2004) · Japanese Journal of Neurosurgery · doi:10.7887/jcns.13.789 · Cited by 1
Glucocorticoids - outcome in patients with glucocorticoid deficiency and Cushing's syndrome
Ragnarsson, Ó. (2012) · Gothenburg University Publications Electronic Archive (Gothenburg University) · Cited by 1
Hormonal Changes in Ageing Men
Plas, E., Madersbacher, S., & Berger, P. (2004) · Neuroimmune biology · doi:10.1016/s1567-7443(04)80012-7 · Cited by 1
The HAART-Induced Metabolic Syndrome
Tsiodras, S., Kelesidis, T., & Mantzoros, C. S. (2006) · Humana Press eBooks · doi:10.1007/978-1-59259-985-1_23 · Cited by 1
Androgens in Primary Care
Anawalt, B. D. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-388-0_22 · Cited by 1
HLA antigens and organ specific antimicrosomal antibodies in patients with autoimmune polyglandular syndromes (APS)
Gromniak, E., Syrenicz, A., Kulig, G., & Pilarska, K. (2003) · Cited by 1
Androgene und Androgenmangel bei Tiermodellen der Osteoporose
Erben, R. G. (2010) · Osteologie/Osteology · doi:10.1055/s-0037-1619931 · Cited by 1
“Die bedeutende Rolle von Androgenen für die Erhaltung des adulten männlichen Skeletts wird durch eine Vielzahl von klinischen Studien untermauert: Orchiektomie oder androgenablative Therapie beim Prostatakarzinom induzieren einen rapiden Knochenverlust, der vor allem den trabekulären Knochen betrifft und mit einem erh…”
Background
Androgens and Anabolic Steroids
Geusens, P., Vanderschueren, D., & Boonen, S. (2000) · Springer eBooks · doi:10.1007/978-1-4471-3825-9_33 · Cited by 1
Endocrinology of male sexual dysfunction
Janmohamed, S. G., & Bouloux, P.-M. G. (2016) · Wiley eBooks · doi:10.1002/9781118746509.ch5 · Cited by 1
Hypogonadism and Androgen Replacement Therapy
Kaufman, J. M., & Seftel, A. D. (2004) · Elsevier eBooks · doi:10.1016/b978-0-7234-3266-1.50018-8 · Cited by 1
Der Einfluss des selektiven Androgenrezeptor-Modulators Enobosarm auf die Skelettmuskulatur im Modellorganismus der osteoporotischen Ratte
Henkies, D. (2020) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-7868 · Cited by 1
Testicular Dysfunction
Meier, C., Seibel, M. J., & Handelsman, D. J. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374602-3.00035-3 · Cited by 1
PAMIDRONATE TO PREVENT BONE LOSS DURING ANDROGEN-DEPRIVATION THERAPY FOR PROSTATE CANCER
Mith, R. S., Overn, J. M. C. G., Ietman, L. Z., Nne, M. A. A., Ayden, L. H., Choenfeld, D. A. A. S., Hilip, P., Antoff, W. K., & Inkelstein, J. O. S. F. (2001) · Cited by 1
Commentary on: A Multicenter Evaluation of Paradoxical Adipose Hyperplasia Following Cryolipolysis for Fat Reduction and Body Contouring: A Review of 8658 Cycles in 2114 Patients
Stefani, W. A. (2021) · Aesthetic Surgery Journal · doi:10.1093/asj/sjab219 · Cited by 1
How Sex Steroids Modulate GH Action on Target Tissues: Long-Term Follow-up in GH-Deficient Adults
Johannsson, G., & Bengtsson, B. (1999) · Springer eBooks · doi:10.1007/978-1-4612-1546-2_21 · Cited by 1
Androgens as Anabolic Agents
Bhasin, S., Woodhouse, L. J., & Storer, T. W. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-388-0_20 · Cited by 1
Wann wird ein Mann gebrechlich? Osteoporose beim Mann
Dam, K. (2001) · Journal für Kardiologie (Krause & Pachernegg GmbH) · Cited by 1
Androgens
ORWOLL, E. S. (1999) · Elsevier eBooks · doi:10.1016/b978-012098655-2/50045-4 · Cited by 1
CARDIOVASCULAR ENDOCRINOLOGY Endogenous Sex Hormones and Cardiovascular Disease in Men
Muller, M., van der Schouw, T., Thijssen, J. H. H., & Grobbee, D. E. (2003) · Cited by 1

Authors: Katznelson, L., Finkelstein, J. S., Schoenfeld, D. A., Rosenthal, D. I., Anderson, E. J., & Klibanski, A.
Affiliations: Massachusetts General Hospital (US)
ORCID: Katznelson, L
Finkelstein, J S
Schoenfeld, D A
Rosenthal, D I
Anderson, E J
Venue: The Journal of Clinical Endocrinology & Metabolism
Publisher: The Endocrine Society
Published: 1996-12
Volume: 81
Issue: 12
Pages: 4358-4365
ISSN: 0021-972X (ISSN-L)
1945-7197
DOI: 10.1210/jcem.81.12.8954042
OpenAlex: W1974568933
Semantic Scholar: 829db808d1847d263af6c33d3397743284ea9f83
Cited by: 791
References: 38
Citations by year: 2026: 2 · 2025: 9 · 2024: 12 · 2023: 13 · 2022: 16 · 2021: 15 · 2020: 15 · 2019: 14 · 2018: 17 · 2017: 18 · 2016: 22 · 2015: 24 · 2014: 17 · 2013: 29 · 2012: 35
FWCI: 19.42
Type: journal article
Language: en
Open access: closed
Locations: The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (5f32dk008738-02)
National Institute of Diabetes and Digestive and Kidney Diseases (DK-08738)
National Center for Research Resources (RR 01066, M01RR001066)
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
Keywords: testosterone replacement therapy, testosterone enanthate, bone mineral density, trabecular bone density, lean body mass, body composition, fat mass, central hypogonadism, hypergonadotropic hypogonadism, bone-specific alkaline phosphatase, urinary deoxypyridinoline, bone turnover markers, men's health, osteoporosis prevention
MeSH terms: Adult, Aged, Body Composition, Bone Development, Humans, Hypogonadism, Cholesterol, HDL, Longitudinal Studies, Male, Middle Aged, Parathyroid Hormone, Growth Hormone, Testosterone, Bone Density

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks